Detalhe da pesquisa
1.
Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multicenter matched-control study.
Eur J Neurol
; 2022 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751475
2.
Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Eur J Neurol
; 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791496
3.
Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study.
Eur J Neurol
; 29(5): 1538-1544, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35102646
4.
Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.
Mult Scler
; 27(14): 2209-2218, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595968
5.
Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study.
Mult Scler Relat Disord
; 65: 104009, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797803
6.
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
PLoS One
; 16(7): e0255316, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314457
7.
Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab-A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry.
Front Neurol
; 11: 676, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849179
8.
Effective cerebrovascular thrombectomy requires well-organized structures : Real world experiences of a regional stroke network between 2012-2015.
Wien Klin Wochenschr
; 129(3-4): 96-101, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108793